Cargando…
A Review on the Therapeutic Role of TKIs in Case of CML in Combination With Epigenetic Drugs
Chronic myeloid leukemia is a malignancy of bone marrow that affects white blood cells. There is strong evidence that disease progression, treatment responses, and overall clinical outcomes of CML patients are influenced by the accumulation of other genetic and epigenetic abnormalities, rather than...
Autores principales: | Amir, Mohd, Javed, Saleem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569791/ https://www.ncbi.nlm.nih.gov/pubmed/34745216 http://dx.doi.org/10.3389/fgene.2021.742802 |
Ejemplares similares
-
Epigenetic Alterations in Renal Cell Cancer With TKIs Resistance: From Mechanisms to Clinical Applications
por: Li, Qinhan, et al.
Publicado: (2021) -
Current CML guidelines overemphasize second generation TKIs: revisiting the paradigm
por: Walia, Anushka, et al.
Publicado: (2023) -
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation
por: Bernardi, Simona, et al.
Publicado: (2019) -
Epigenetic Reprogramming and Emerging Epigenetic Therapies in CML
por: Bugler, Jane, et al.
Publicado: (2019) -
Genomic Copy Number Variants in CML Patients With the Philadelphia Chromosome (Ph+): An Update
por: Zhang, Heyang, et al.
Publicado: (2021)